Eric Clapton, Musician, and his Covid Vaccine Injury – Safe and Effective?

Source of Featured Image

“… ramped up from, on a scale of ten, say, from 3 to … 8 or 9 … Agony and chronic pain …”

(Go to 10:20 minutes for screenshot.)

Please note: The advertisements are NOT mine.

Dear Pain Matters readers,

Sadly, countless people suffer from severe adverse reactions including chronic pain following their experimental Covid mRNA injections including famous musician, Eric Clapton.

Quoting Eric Clapton in an interview with Robin Monotti, Italian architect and film producer, regarding his adverse reaction to the AstraZeneca injection:

“I can’t sleep because of the pain … the vaccine took my immune system and just shook it around …

… and I went and had the jab and I got a little green [card] (like a library card), and I thought that’s what I’m going to show the people when I get on the plane. … Within several hours, I was shaking like a leaf and I went to bed early and I couldn’t get warm … I thought … am I running a fever? I was boiling hot and sweating, and then I was cold. … I was out for the count for about a week.

I had been preparing for a project where I was going to be playing acoustic guitar with a couple of musicians and we were going to film it that week. Knocked me out and I had to start again from scratch. … It didn’t come off as well as I would like to … It was a huge setback and it frightened the **** out of me because I didn’t know how long it would last. I then started to find out more …

… bit by bit, I realised that I probably shouldn’t have had the first jab but then I was offered the second [jab]. I thought, well, … what’s the point in … stopping now? So I went and had the second [jab], … And then it got really bad and within about a week, I had lost my hands – [they] didn’t really work. … I suffered from a condition … called peripheral neuropathy, which is nerve damage pain, … which means that … I can get numb, or pins and needles. …

This [pain] … ramped up from, say, 3 to … 8 or 9 (on a scale of 10). Agony and chronic pain … I have gigs to do, I have recording work to do, but I can’t … play the guitar, it’s not fun and it’s something I do … then when I put [the guitar] down, [the pain] is there until I go to bed. I take sleeping pills because I can’t sleep because of the pain, and that’s … not a good way to live … the vaccine took my immune system and just shook it around again, and that’s still going on …

… and I called my … NHS doctor after the second jab and I said, “I’ve been told there’s a yellow card system … where I can complain about after-effects?“ He said … , “I’ll fill in the report …” …

I lost the use of my hands for about 3 weeks, so I thought I was in real trouble. That’s about that point I was invited by Robin Monotti to talk about it … because I realised that … I wasn’t the only one that was suffering adverse reactions … I  can’t touch anything cold or hot, I have to use these [gloves], otherwise my hands will begin to burn and they’ll stay burnt all day.

… that’s my experience from having had the second jab … I went to my doctor … and said, you know, I can’t have any more vaccinations. This is not possible for me because I don’t know what will happen. I don’t know what will happen next. …”        

Source:

Eric Clapton: Exclusive & Uncensored Oracle Films – Robin Monotti in conversation with Eric Clapton

(24 minutes; transcript available; 14 June 2021; 492,000 views)

https://www.youtube.com/watch?v=4OHmMKrVbNk

via https://t.me/robinmg/26449

Quoting Eric Clapton in another interview with Robin Monotti:

“In February [2021] this year, before I learned about the nature of the [Covid] vaccines and being 76 with emphysema, I was in the avant garde. I took the first jab of [AstraZeneca] and straight away, [I] had severe reactions which lasted 10 days, I recovered eventually and was told it would be 12 weeks before the second one…

About 6 weeks later, I was offered and took the second [AstraZeneca] shot, but with a little more knowledge of the dangers. Needless to say, the reactions were disastrous. My hands and feet were either frozen, numb or burning, and pretty much useless for 2 weeks. I feared I would never play again. I suffer with peripheral neuropathy and [I] should never have gone near the needle. But the propaganda said the vaccine was safe for everyone. …”

Source:

Robin Monotti: A Conversation with Eric Clapton | Oracle Films

(22-minutes; transcript available; 16 June 2021)

via https://t.me/robinmg/3377,

https://t.me/robinmg/3377 and

https://t.me/robinmg/26449

Thank you very much, Robin Monotti, for sharing Eric Clapton‘s experiences that will hopefully help others struggling with side effects including chronic pain, post-Covid injection.

In closing today, I leave you with 2 songs by Eric Clapton, one written in 2021 and the second one written in 1992. Like so many of his songs, the lyrics to these songs are laden with meaning hence worthwhile analysing in greater detail:

This Has Gotta Stop

…

I knew that somethin’ was goin’ on wrong
When you started layin’ down the law
I can’t move my hands, I break out in sweat
I wanna cry, can’t take it anymore

…

I’ve been around long, long time
Seen it all, and I’m used to being FREE
I know who I am, try to do what’s right
So lock me up and throw away the key

This has gotta stop
Enough is enough
I can’t take this BS any longer
It’s gone far enough
If you wanna claim my soul
You’ll have to come and break down this door

Tears In Heaven

https://www.youtube.com/watch?v=JxPj3GAYYZ0

Sabina Walker

Master in Applied Science (Neuroscience)

Blogger, Pain Matters

About

ADDITIONAL REFERENCES

(1) Eric Clapton: I should never have gone near the needle.

https://www.americasfrontlinedoctors.org/frontline-news/eric-clapton-after-covid-vaccination-i-should-never-have-gone-near-the-needle

via https://t.me/robinmg/3380

(2) https://t.me/robinmg/3377

(3) Makis, William MD

Musicians Injured – Eric Clapton: “I can’t sleep because of the pain … the vaccine took my immune system and just shook it around” –

Eric Clapton bravely discusses his neurological COVID-19 vaccine injuries (11 February 2023)

https://makismd.substack.com/p/eric-clapton-i-cant-sleep-because

Patching up Pain with a Lidocaine 5% Patch

Dear Pain Matters readers,

Treatment via a lidocaine 5% patch may offer significant pain relief for patients including cancer patients with focal nerve pain.

Specifically, patients with severe and localised nerve pain including one of the following painful conditions may benefit from a lidocaine 5% patch that topically delivers lidocaine:

• Postherpetic neuralgia and herpes zoster (shingles);
• Non-diabetic and diabetic peripheral neuropathy;
• Trigeminal (orofacial) neuropathic pain;
• Erythromelalgia;
• Chronic low back pain (Hines et al, 2002);
• Post-surgical neuropathic pain (e.g. following surgery for cancer or otherwise); and
• Neuropathic pain directly attributable to cancer.

Lidocaine works by blocking sodium channels including Nav1.7 that underlie many nerve pain conditions (and other mechanisms).  The release of very small amounts of lidocaine transdermally via the patch ensures that motor and cardiac functions remain unaffected.

While topical lidocaine patches leads to pain relief in 29%-80% of treated patients, likely via small-fiber block, it is not clear why lidocaine patches may work better in some patients than in others (Krumova et al, 2012).

The topical lidocaine patch, measuring 10 cm X 14 cm, should only be applied on top of unbroken skin and where the pain is the greatest.  Patches should only be used by patients who are not allergic to local anaesthetics including lidocaine and who are not sensitive to the adhesive material itself.

The recommended maximum daily dose is 3 patches worn simultaneously for 12 hours at a time.  Since the lidocaine patch can only be worn for 12 hours at a time each day, other pain medications may be necessary, especially during sleep.

Lidocaine 5% Patch Treatment for Severe Chronic Pain – Successful Cases

Four Patients with Severe Low Back Pain

Four (4) patients aged 30 to 64 had successful lidocaine 5% patch treatment for severe low back pain as well as leg pain, foot pain (including CRPS, left foot) and/or neck pain.  Their pain included burning and stabbing nerve pain.  Specifically:

(1) A 53-year old woman had severe low back pain since a motor vehicle accident in July 2000.  She also endured right leg pain and some right foot numbness.  The patient said that the lidocaine 5% patch treatment ‘helped about 80%’.

(2) A 30-year old woman suffered low back pain, neck pain and right leg pain including burning and stabbing nerve pain.  She had a lifting and twisting injury in 1996.  The patient stated that her pain had dropped from ‘8’ to ‘5’ thanks to lidocaine 5% patch treatment.

(3) A 64-year old man suffered low back pain after a lifting injury in 1987.  He also suffered CRPS in his left lower leg and foot.  Lidocaine 5% patch treatment offered effective pain relief for his CRPS, left foot, and his painful lower back.  Furthermore, he was able to stop all other pain medication.

(4) A 50-year old woman suffered low back pain and right leg pain including aching and burning pain for 22 years.  Lidocaine 5% patch treatment offered effective pain relief.

There were no adverse effects resulting from lidocaine 5% patch treatment (Hines et al, 2002).   

A Young Patient With Episodic Erythromelalgia In Both Feet

A 15-year old Caucasian girl who suffered disabling pain during episodes of erythromelalgia in both feet derived complete pain relief almost immediately after applying lidocaine 5% patches to the top of both of her feet, both at rest and during almost normal levels of activity.  

Post-lidocaine patch treatment, the young patient was able to run around the track at school, play soccer, return to her physical education class, march in the school band and walk around the shopping mall for almost an hour.  As long as she did not overdo her activities, she was able to obtain 100% relief during the 12 hours of lidocaine patch use, plus another 2-3 hours after patch removal.  The patient slept without the patches.

Whilst offering complete local pain relief and no side effects, the lidocaine patch was unable to prevent the other symptoms of erythromelalgia from occurring including bright red skin and over-heated feet following physical exertion.

(Davis & Sandroni, 2002, including both images).

Two (2) Patients With Nerve Pain       

1st Patient – A 74-Year Old Female Patient With Herpes Zoster (Shingles)

Despite prompt treatment for a herpes zoster skin rash, a 74-year old woman developed stabbing and burning pain in her rash-affected area.  The patient was offered 2 lidocaine patches daily to cover the painful region.  Within 4 weeks treatment, the patient obtained 75% relief from pain caused by her herpes zoster skin rash.  Most of her systemic pain medications were stopped.

2nd Patient – A 56-Year Old Man With Severe Neuropathic Pain Syndrome Following Microsurgery For A Neuroma in Right Foot 

A 56-year old man suffered severe nerve pain shortly after microsurgery to his right foot due to an interdigital neuroma.  His painful symptoms included severe burning pain, mechanical hyperalgesia and allodynia, together with other symptoms.  As a result, he could no longer work, was unable to wear socks and shoes (only sandals) and withdrew from his family and friends.

After applying half of a lidocaine 5% patch daily onto his painful skin region, the patient reported positive results.  After 8 weeks of lidocaine patch treatment, the patient enjoyed an 80% reduction in overall pain levels and consequently returned to work.  There were no side effects and the patients was able to stop all other analgesics (Hans et al, 2010).

Trigeminal (Orofacial) Neuropathic Pain And Lidocaine Patch Treatment

A British study revealed that lidocaine 5% patch treatment led to improved pain levels in 12 of 14 trigeminal pain patients including oral surgery patients.  Nine (9) of the 12 patients were able to reduce or stop their intake of other pain medications.  Given that the majority (12/14) patients with trigeminal nerve pain benefited from lidocaine 5% patch treatment, further studies are warranted (Khawaja et al, 2013).

Cancer Patients And Lidocaine Patch Treatment

A large Australian study in a comprehensive cancer centre revealed that lidocaine 5% patch treatment had a ‘potent analgesic effect’ in 24 of 95 (25%) patients while another 23 patients (24%) reported a ‘partial effect’.  Given that almost half (47/95, or 49%) of all cancer patients with nerve pain benefited from lidocaine 5% patch treatment, further research is warranted (Fleming and O’Connor, 2009).

Current Study Involving Lidocaine Patch for Lower Limb Amputation Pain

A Belgium-based trial is currently recruiting up to 20 patients with pain following above- or below-knee amputation to assess the effectiveness of lidocaine patch treatment for peripherally-mediated phantom limb pain and/or stump scar hyperalgesia (Hatem, 2016).  Stay tuned for updates…

Summary

While lidocaine 5% patch treatment is expensive and there is a small risk of a skin rash, many patients with focal nerve pain obtain significant pain relief from the lidocaine 5% patch, a targeted peripheral analgesic that is non-addictive and safe for long-term use.  

Now that’s a good way to patch up pain!

Sabina Walker

Blogger, Pain Matters

REFERENCES

(1) Davis, Mark D P; Sandroni, Paola. Lidocaine Patch for Pain of Erythromelalgia; Arch Dermatol. Jan 2002;138(1):17-19

doi:10.1001/archderm.138.1.17

http://jamanetwork.com/journals/jamadermatology/fullarticle/478622

(2) Fleming JA, O’Connor BD.

Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre.

(Utilisation des timbres de lidocaïne pour la douleur neuropathique dans un centre d’oncologie)

Pain Research & Management : The Journal of the Canadian Pain Society. 2009;14(5):381-388

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779156/#!po=28.7879

(3) Hans G, Robert D, Verhulst J, Vercauteren M. Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician. Clinical pharmacology : advances and applications. 2010;2:65-70

doi: 10.2147/CPAA.S9795

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262358/

(4) Hines R, Keaney D, Moskowitz MH, Prakken S. Use of Lidocaine Patch 5% for Chronic Low Back Pain: A Report of Four Cases. Pain Med 2002; 3 (4): 361-365

doi: 10.1046/j.1526-4637.2002.02051.x

https://academic.oup.com/painmedicine/article-lookup/doi/10.1046/j.1526-4637.2002.02051.x

(5) Khawaja N, Yilmaz Z, Renton T. Case studies illustrating the management of trigeminal neuropathic pain using topical 5% lidocaine plasters. British Journal of Pain. 2013;7(2):107-113.

doi:10.1177/2049463713483459

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590123/#!po=23.6842

(6) Hatem, Samar; A Trial of Lidocaine Patch for Lower Limb Amputation Pain (Trial ongoing since 2016); Brugmann University Hospital

https://clinicaltrials.gov/ct2/show/study/NCT02696720?view=results

(7) Krumova EK1, Zeller M, Westermann A, Maier C. Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers. Pain. 2012 Feb;153(2):273-80.

doi: 10.1016/j.pain.2011.08.020.

https://www.ncbi.nlm.nih.gov/pubmed/21995882

(8) Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain. 2000 Sep;16(3):205-8.

https://www.ncbi.nlm.nih.gov/pubmed/11014393

(9) Many Other Lidocaine Patch/Pain Studies Can Be Found Here:

http://www.druglib.com/druginfo/lidoderm/abstracts/